drugset
drugset / Trial / NCT03077165

Dose-response Relationship Study of S42909 on Leg Ulcer Healing

NCT03077165 ↗

Phase 2 Completed 121 enrolled Ilkos Therapeutic Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

Dose-response relationship study of S42909 on leg ulcer healing after oral repeated administration in patients with active venous leg ulcer.

Timeline

Start
2017-09-12
Primary completion
2019-12-12
Completion
2020-01-22

Drugs

EvaluationDrugModalityDoseRoute
Subject S42909 Unknown 100 mg Oral
Subject S42909 Unknown 200 mg Oral
Subject S42909 Unknown 400 mg Oral
Subject S42909 Unknown 800 mg Oral
Subject S42909 Unknown 1200 mg Oral

Indications

ulcer of lower limbs